Ramadico Pharmaceuticals Private Limited

Ramadico Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U51397DL2012PTC239156 Incorporated 23 July 2012 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹11.27 Lakh
▲ 119% YoY
Net loss · FY 2024
₹62,518
Net margin -5.5%
EBITDA · FY 2024
-₹36,959
EBITDA margin -3.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Ramadico Pharmaceuticals Private Limited

Data last updated:

Ramadico Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 July 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2012PTC239156. Its GSTIN is 07AAGCR0399Q2ZL (Delhi). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harish Kumar and Sandeep.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 1 26 – C Ground Floor Khasra No. 11/1 210 Nahar Pur Village Sector – 7 Rohini, Delhi, India – 110085.

As per the financials filed for FY 2024, the company reported a revenue of ₹11.27 Lakh, a growth of 119% compared to the previous year. For the same year it recorded a net loss of ₹62,518 (net margin -5.5%) and EBITDA of -₹36,959 (EBITDA margin -3.3%).

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51397DL2012PTC239156
Registration Number 239156
Incorporation Date 23 July 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Ramadico Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Shop No. 1 26 – C Ground Floor Khasra No. 11/1 210 Nahar Pur Village Sector – 7 Rohini, Delhi, India – 110085
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Ramadico Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Ramadico Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ramadico Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Ramadico Pharmaceuticals Private Limited, buy the company report.

Financials of Ramadico Pharmaceuticals Private Limited

FY 2025 filings available

Ramadico Pharmaceuticals Private Limited reported revenue of ₹11.27 Lakh (up 119% YoY) for FY 2024.

Revenue · FY 2024
₹11.27 Lakh ▲ 119%
Net loss · FY 2024
₹62,518 margin -5.5%
EBITDA · FY 2024
-₹36,959 margin -3.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 119%
EBITDA CAGR growth
1 year
▼ 319%
3 years · compounded
▼ 95%
5 years · compounded
▼ 6%

Revenue rose 119% in the latest year. EBITDA fell 319% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹36,959
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹62,518
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-3.3%
Net Profit Margin-5.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ramadico Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ramadico Pharmaceuticals Private Limited

Ramadico Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Harish KumarDirector27 Oct 20206 Years 0 MonthsCurrent
SandeepDirector27 Oct 20206 Years 0 MonthsCurrent

Auditor

Ramadico Pharmaceuticals Private Limited is audited by VERMA GARG & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
VERMA GARG & ASSOCIATESFY 2020015888N

Shareholding

The shareholding of Ramadico Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ramadico Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ramadico Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ramadico Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AAGCR0399Q2ZLDelhiActive31 Mar 2021

To see the full GST registrations and return filing status of Ramadico Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ramadico Pharmaceuticals Private Limited has 10 board changes on record since 2015: 2 appointments and 8 cessations. The latest: Usha Singh ceased to be Director on 17 Dec 2020.

AGM
Ramadico Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ramadico Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Usha Singh ceased to be Director.
Ceased
Harish Kumar ceased to be Additional Director.
Ceased
Sandeep ceased to be Additional Director.
Appointed
Harish Kumar was appointed as Director.
Appointed
Sandeep was appointed as Director.
Ceased
Tushar Malhotra ceased to be Additional Director.
Ceased
Chander Bhan Singh ceased to be Director.
Ceased
Anuj Gupta ceased to be Director.
Ceased
Girish Pal Cally ceased to be Director.
Ceased
Savita Goyal ceased to be Director.

1 earlier event is in the company report.

Frequently asked questions

Ramadico Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 July 2012 (14+ years old) and is registered under CIN U51397DL2012PTC239156.

Ramadico Pharmaceuticals has 2 current directors:

The latest financial statements of Ramadico Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Ramadico Pharmaceuticals is 07AAGCR0399Q2ZL, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Ramadico Pharmaceuticals is U51397DL2012PTC239156. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ramadico Pharmaceuticals was incorporated on 23 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.

Usha Singh ceased to be Director on 17 Dec 2020. Harish Kumar ceased to be Additional Director on 08 Dec 2020. Sandeep ceased to be Additional Director on 08 Dec 2020. Ramadico Pharmaceuticals has 10 board changes on record in total.

The registered office of Ramadico Pharmaceuticals is at Shop No. 1 26 – C Ground Floor Khasra No. 111 210 Nahar Pur Village Sector – 7 Rohini, Delhi, India – 110085.

Ramadico Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Ramadico Pharmaceuticals is compliant as of 07 September 2026. The company is actively filing with the Registrar of Companies.